Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

Anne Langsted1,2,3, Børge G Nordestgaard1,2,3

  • 1Department of Clinical Biochemistry.

Insights

Low-density lipoprotein (LDL) and lipoprotein(a) show similar causal risks for heart attack. However, lipoprotein(a) is a more significant factor for cardiovascular and all-cause mortality, potentially due to its structure.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
  • Lipid profiles, including low-density lipoprotein (LDL) cholesterol and lipoprotein(a) [Lp(a)], are critical in assessing CVD risk.
  • Understanding the distinct causal roles of LDL and Lp(a) is essential for targeted prevention strategies.

Purpose of the Study:

  • To directly compare the causal roles of LDL cholesterol and Lp(a) in cardiovascular disease and mortality.
  • To review recent scientific literature on the comparative impact of LDL and Lp(a) on health outcomes.

Main Methods:

  • Observational analyses of approximately 100,000 individuals from the Copenhagen General Population Study.
  • Genetic analyses to determine causal risk ratios for myocardial infarction and mortality.
  • Assessment of hazard ratios for myocardial infarction, cardiovascular mortality, and all-cause mortality per unit increase in LDL and Lp(a) cholesterol.

Main Results:

  • On a cholesterol basis, LDL and Lp(a) demonstrated similar causal risk for myocardial infarction (HR 1.3 for LDL, 1.6 for Lp(a)).
  • Genetic analyses indicated comparable causal risk ratios for myocardial infarction (2.1 for LDL, 2.0 for Lp(a)).
  • Lp(a) showed a greater association with mortality risk compared to LDL (HR 1.18 vs. 1.05 for cardiovascular mortality, 1.07 vs. 1.01 for all-cause mortality per 15 mg/dl increase).

Conclusions:

  • Lipoprotein(a) is a significant causal factor for cardiovascular mortality, potentially exceeding the impact of LDL cholesterol.
  • The structural characteristics of Lp(a), particularly its resemblance to plasminogen via apolipoprotein(a) kringle IV-2, may contribute to its pathogenicity beyond its cholesterol content.
  • Further research into Lp(a) structure and function is warranted for novel therapeutic targets.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
662
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
504
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
530
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
6.1K